Real-time enrollment status for this leiomyosarcoma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:07 PM UTC
| NCT Number | NCT06528769 |
| Recruiting Status | Recruiting |
| Condition | Leiomyosarcoma |
| Phase | PHASE2 |
| Target Enrollment | 16 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Gabriel Tinoco |
| Last Updated on CT.gov | September 30, 2025 (Sep 30, 2025) |
As of July 16, 2026: Clinical trial NCT06528769 is currently recruiting participants. This phase2 study for leiomyosarcoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Gabriel Tinoco. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06528769 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06528769 was last updated Sep 30, 2025 (September 30, 2025). HelloStudys verifies this status automatically.